MR-guided Laser Interstitial Thermal Therapy mesencephalotomy for medically intractable malignant pain
By
Mickael Aubignat
Jean-Marc Constans
Martial Ouendo
Jean-Philippe Arnault
Claire Josse
Christine Desenclos
Michel Lefranc
May 2, 2025
Clinical Scorecard: Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy for Persistent Malignant Pain Management through Mesencephalotomy
At a Glance
Category Detail
Condition Intractable malignant pain due to metastatic melanoma Key Mechanisms Targeted lesioning of spinothalamic and trigeminothalamic pathways via MRgLITT mesencephalotomy Target Population Patients with refractory malignant pain unresponsive to conventional therapies Care Setting Palliative care with minimally invasive neurosurgical intervention
Key Highlights
MRgLITT offers real-time imaging-guided precision for stereotactic mesencephalotomy. Procedure resulted in significant pain reduction (VAS >7 to <3) without neurological deficits. Minimally invasive approach preserves sensory discrimination and reduces opioid use. Guideline-Based Recommendations
Diagnosis
Use high-resolution MRI with gadolinium, 3D-SWAN, inversion recovery, and diffusion tensor imaging for preoperative planning. Integrate imaging datasets with stereotactic planning software to localize spinothalamic tract target. Management
Perform robot-assisted MRgLITT mesencephalotomy under stereotactic guidance and local anesthesia for electrode placement. Deliver stepwise thermal ablation with real-time thermometry and safety cutoffs to create precise lesioning. Consider MRgLITT mesencephalotomy for refractory malignant pain when other neuromodulation or lesioning options are unsuitable. Monitoring & Follow-up
Use intraoperative macrostimulation testing to confirm target placement without adverse effects. Monitor temperature zones during ablation to prevent overheating and collateral damage. Postoperative assessment of pain scores and sensory function, including thermal perception testing. Risks
Potential morbidity minimized by real-time imaging and robotic precision. No neurological deficits or sensory discrimination loss observed in reported case. Risk of cancer progression remains independent of procedure. Patient & Prescribing Data
Adult patients with metastatic melanoma experiencing severe, treatment-resistant pain
MRgLITT mesencephalotomy enabled substantial reduction in opioid and adjunctive medication use with improved pain control.
Clinical Best Practices
Employ multidisciplinary evaluation for patient selection and individualized treatment planning. Utilize advanced imaging and robotic platforms for precise targeting and safety. Implement stepwise thermal energy delivery with continuous thermometry monitoring. Assess sensory function postoperatively to ensure preservation of thermal perception. Consider MRgLITT mesencephalotomy as a palliative option when conventional therapies fail. References
